[Federal Register Volume 89, Number 165 (Monday, August 26, 2024)]
[Notices]
[Pages 68452-68453]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18943]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity

AGENCY: Substance Abuse and Mental Health Services Administration, 
Department of Health and Human Services (HHS).

ACTION: Notice of intent to award supplemental funding.

-----------------------------------------------------------------------

SUMMARY: This notice is to inform the public that the Substance Abuse 
and Mental Health Services Administration (SAMHSA) is supporting 
administrative supplements in scope of the parent award for the five 
eligible grant recipients funded in FY22 and FY23 under the Grants to 
Prevent Prescription Drug/Opioid Overdose Program (PDO), Notice of 
Funding Opportunity (NOFO) SP-21-002. Recipients may receive up to 
$279,266 each for a total of $1,396,330 across the program. These 
recipients have a project end date for use of these supplemental funds 
of September 29, 2025. The supplemental funding will be used to fund a 
comprehensive Training of Trainer (ToT) model to enhance workforce 
development and capacity in the arena of preventing prescription drug/
overdose related deaths and adverse

[[Page 68453]]

events within existing projects funded under the PDO program.

FOR FURTHER INFORMATION CONTACT: Shannon Hastings, NOFO Lead, Division 
of Targeted Prevention, Center for Substance Abuse Prevention, 
Substance Abuse and Mental Health Services Administration, 5600 Fishers 
Lane, Rockville, MD 20857, email: [email protected], telephone: 
(240) 276-1869.

SUPPLEMENTARY INFORMATION: 
    Funding Opportunity Title: FY 2021 Grants to Prevent Prescription 
Drug/Opioid Overdose-Related Deaths (PDO) SP-21-002.
    Assistance Listing Number: 93.243.
    Authority: Section 516 of the Public Health Service Act, as 
amended, 42 U.S.C. 290bb-22.
    Justification: These supplement awards will be offered to the FY22 
and FY23 cohorts under SP-21-002. Supplemental funding will be awarded 
to these cohorts because they have over three years remaining in their 
awards to implement their projects. The cohorts, which are comprised of 
state grantees, will receive a larger supplemental award per recipient 
which will increase opportunity to implement the activities. These 
cohorts have implemented existing activities well positioned to be 
leveraged under the ToT model. These factors will benefit SAMHSA so 
that the agency will be able to track the effects of the ToT model over 
time. This work aligns with SAMHSA's goals of expanding access to 
naloxone and other opioid overdose reversal medications and enhances 
SAMHSA's naloxone saturation and overdose prevention efforts.
    This is not a formal request for application. Assistance will only 
be provided to the 5 PDO grant recipients funded in FY22 and FY23 under 
the Grants to Prevent Prescription Drug/Opioid Overdose Program, NOFO 
(SP-21-002) based on the receipt of a satisfactory application and 
associated budget that is approved by a review group.

    Dated: August 20, 2024.
Ann Ferrero,
Public Health Analyst.
[FR Doc. 2024-18943 Filed 8-23-24; 8:45 am]
BILLING CODE 4162-20-P